oral tirzepatide weight loss GLP-1 for The dual Semaglutide vs Tirzepatide: Which GLP-1

Profound RF

Mounjaro (tirzepatide) is an FDA-approved injectable drug for type 2 diabetes mellitus, and is commonly used off-label for weight loss

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide receptors and GLP-1 receptors simultaneously

NICE notes that room temperature storage is safe only up to 30 C, and only for a maximum of six weeks after first use

H.NieuwdorpM.Orho-MelanderM.et al (2024)

SEM exhibits anti-inflammatory properties, reducing the release of pro-inflammatory cytokines and potentially lessening the neuronal damage associated with excitotoxicity [44,47,48]